Filter by Deal Type:
Only premium members can access all failed mergers list.
Note: Premium members can sort this table by Return, Annualized Return and Estimated Closing.
| Target | Announced Date | Acquirer | Deal Type | Closing Value | Deal Price | Termination Date | Price at Termination | Last Price | Reason for Termination | Performance Since Termination | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| STAAR Surgical Company (STAA) chart | 8/05/25 | Alcon Inc. (ALC) | Cash | $1.65B | $30.75 | 1/06/26 | $22.29 | $26.44 | Shareholder Rejection | 18.62% | |
| Core Scientific, Inc. (CORZ) chart | 7/07/25 | CoreWeave, Inc. (CRWV) | Stock | $9B | $20.40 | 10/30/25 | $20.74 | $20.94 | Shareholder Rejection | 0.96% | |
| TaskUs, Inc. (TASK) chart | 5/09/25 | Blackstone and TaskUs Co-Founders (BX) | Cash | $1.62 B | $16.50 | 10/08/25 | $14.96 | $5.83 | Shareholder Rejection | -61.03% | |
| LENSAR, Inc. (LNSR) chart | 3/24/25 | Alcon Inc. (ALC) | Special Conditions | $430 M | $14.00 | 3/16/26 | $6.89 | $5.80 | Regulatory Issues | -15.82% | |
| Shutterstock, Inc. (SSTK) chart | 1/07/25 | Getty Images Holdings, Inc. (GETY) | Cash Plus Stock | $3.7 B | $33.07 | 7/07/26 | $8.72 | $7.41 | Regulatory Issues | -15.02% | |
| Cross Country Healthcare, Inc. (CCRN) chart | 12/04/24 | Aya Healthcare (N/A) | Cash | $615 M | $18.61 | 12/04/25 | $7.53 | $13.24 | Regulatory Issues | 75.83% |
Note: Premium members can sort this table by Target, Announced Date, Termination Date and Performance Since Termination. Desktop Version
| Target | Announced Date | Termination Date | Performance Since Termination | |
|---|---|---|---|---|
| STAAR Surgical Company (STAA) chart | 8/05/25 | 1/06/26 | 18.62% | |
| Core Scientific, Inc. (CORZ) chart | 7/07/25 | 10/30/25 | 0.96% | |
| TaskUs, Inc. (TASK) chart | 5/09/25 | 10/08/25 | -61.03% | |
| LENSAR, Inc. (LNSR) chart | 3/24/25 | 3/16/26 | -15.82% | |
| Shutterstock, Inc. (SSTK) chart | 1/07/25 | 7/07/26 | -15.02% | |
| Cross Country Healthcare, Inc. (CCRN) chart | 12/04/24 | 12/04/25 | 75.83% |